{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T13:28:56Z","timestamp":1782826136295,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institute for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Alzheimer's Society of Canada"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.mcn.2018.03.009","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T23:14:03Z","timestamp":1521760443000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Cystatin C promotes tau protein phosphorylation and causes microtubule instability by inhibiting intracellular turnover of GSK3\u03b2 in neurons"],"prefix":"10.1016","volume":"89","author":[{"given":"Jinhai","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen A.","family":"Marcellus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xike","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant K.","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcn.2018.03.009_bb0005","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1016\/S0021-9258(18)67380-6","article-title":"Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids","volume":"261","author":"Abrahamson","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2018.03.009_bb0010","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1073\/pnas.121119298","article-title":"Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments\/straight filaments","volume":"98","author":"Alonso","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2018.03.009_bb0015","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrn2494","article-title":"Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses","volume":"9","author":"Bertram","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"Pt 1","key":"10.1016\/j.mcn.2018.03.009_bb0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1042\/bj2990219","article-title":"Differential changes in the association and dissociation rate constants for binding of cystatins to target proteinases occurring on N-terminal truncation of the inhibitors indicate that the interaction mechanism varies with different enzymes","volume":"299","author":"Bjork","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.mcn.2018.03.009_bb0025","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.0308512100","article-title":"Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses","volume":"101","author":"Blalock","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2018.03.009_bb0030","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0896-6273(93)90057-X","article-title":"Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding","volume":"10","author":"Bramblett","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2018.03.009_bb0035","doi-asserted-by":"crossref","first-page":"10998","DOI":"10.1073\/pnas.88.24.10998","article-title":"Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease","volume":"88","author":"Cataldo","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2018.03.009_bb0040","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1212\/01.WNL.0000151980.42337.44","article-title":"Cystatin C as a risk factor for Alzheimer disease","volume":"64","author":"Cathcart","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2018.03.009_bb0045","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1212\/WNL.55.6.763","article-title":"A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease","volume":"55","author":"Crawford","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2018.03.009_bb0050","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0002-9440(10)61781-6","article-title":"Elevation of cystatin C in susceptible neurons in Alzheimer's disease","volume":"159","author":"Deng","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mcn.2018.03.009_bb0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1515\/BC.2001.015","article-title":"Cystatins as calpain inhibitors: engineered chicken cystatin- and stefin B-kininogen domain 2 hybrids support a cystatin-like mode of interaction with the catalytic subunit of mu-calpain","volume":"382","author":"Diaz","year":"2001","journal-title":"Biol. Chem."},{"key":"10.1016\/j.mcn.2018.03.009_bb0060","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1212\/WNL.58.4.664","article-title":"A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD","volume":"58","author":"Dodel","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2018.03.009_bb0065","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1001\/archneur.57.11.1579","article-title":"Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease","volume":"57","author":"Finckh","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.mcn.2018.03.009_bb0070","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrneurol.2013.223","article-title":"Alzheimer disease therapy\u2014moving from amyloid-beta to tau","volume":"9","author":"Giacobini","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.mcn.2018.03.009_bb0075","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2018.03.009_bb0080","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","article-title":"Tau phosphorylation: the therapeutic challenge for neurodegenerative disease","volume":"15","author":"Hanger","year":"2009","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.mcn.2018.03.009_bb0085","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000209278","article-title":"Flanking markers of cystatin c (CST3) gene do not show association with Alzheimer's disease","volume":"27","author":"Helisalmi","year":"2009","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.mcn.2018.03.009_bb0090","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1128\/MCB.02227-06","article-title":"The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death","volume":"28","author":"Hongisto","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.mcn.2018.03.009_bb0095","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer's disease","volume":"104","author":"Hooper","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mcn.2018.03.009_bb0100","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jalz.2010.04.006","article-title":"Alzheimer's disease, a multifactorial disorder seeking multitherapies","volume":"6","author":"Iqbal","year":"2010","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.mcn.2018.03.009_bb0105","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/ana.20639","article-title":"Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers","volume":"58","author":"Iqbal","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.mcn.2018.03.009_bb0110","doi-asserted-by":"crossref","first-page":"8187","DOI":"10.1038\/srep08187","article-title":"Truncation and activation of GSK-3beta by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease","volume":"5","author":"Jin","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mcn.2018.03.009_bb0115","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/ng.2007.23","article-title":"Cystatin C modulates cerebral beta-amyloidosis","volume":"39","author":"Kaeser","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mcn.2018.03.009_bb0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2990.2006.00795.x","article-title":"Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration","volume":"33","author":"Leroy","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.mcn.2018.03.009_bb0125","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1021\/bi051634r","article-title":"Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism","volume":"45","author":"Li","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.mcn.2018.03.009_bb0130","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1074\/jbc.M606347200","article-title":"Phosphorylation of protein phosphatase 1 by cyclin-dependent protein kinase 5 during nerve growth factor-induced PC12 cell differentiation","volume":"282","author":"Li","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2018.03.009_bb0135","doi-asserted-by":"crossref","first-page":"41667","DOI":"10.1074\/jbc.M206405200","article-title":"Enhanced glycogen synthase kinase-3beta activity mediates hypoxia-induced apoptosis of vascular smooth muscle cells and is prevented by glucose transport and metabolism","volume":"277","author":"Loberg","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2018.03.009_bb0140","doi-asserted-by":"crossref","first-page":"20569","DOI":"10.1074\/jbc.M111.220962","article-title":"Early growth response 1 (Egr-1) regulates phosphorylation of microtubule-associated protein tau in mammalian brain","volume":"286","author":"Lu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2018.03.009_bb0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/emboj\/20.1.27","article-title":"Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice","volume":"20","author":"Lucas","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.mcn.2018.03.009_bb0150","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1212\/WNL.57.2.337","article-title":"Lack of an association between cystatin C gene polymorphisms in Japanese patients with Alzheimer's disease","volume":"57","author":"Maruyama","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2018.03.009_bb0155","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.arr.2016.06.003","article-title":"Cystatin C in aging and in Alzheimer's disease","volume":"32","author":"Mathews","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.mcn.2018.03.009_bb0160","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/ng.2007.29","article-title":"Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models","volume":"39","author":"Mi","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mcn.2018.03.009_bb0165","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.brainres.2005.10.063","article-title":"Neuronal cell death induced by cystatin C in vivo and in cultured human CNS neurons is inhibited with cathepsin B","volume":"1066","author":"Nagai","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.mcn.2018.03.009_bb0170","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.neurobiolaging.2013.01.008","article-title":"Unfolded protein response activates glycogen synthase kinase-3 via selective lysosomal degradation","volume":"34","author":"Nijholt","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mcn.2018.03.009_bb0175","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0014-5793(97)01604-9","article-title":"Two-step mechanism of inhibition of cathepsin B by cystatin C due to displacement of the proteinase occluding loop","volume":"422","author":"Nycander","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mcn.2018.03.009_bb0180","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2018.03.009_bb0185","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/45159","article-title":"Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration","volume":"402","author":"Patrick","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2018.03.009_bb0190","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00005072-199701000-00007","article-title":"Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain","volume":"56","author":"Pei","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.mcn.2018.03.009_bb0195","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1097\/00005072-199909000-00011","article-title":"Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes","volume":"58","author":"Pei","year":"1999","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.mcn.2018.03.009_bb0200","doi-asserted-by":"crossref","first-page":"22276","DOI":"10.1074\/jbc.M116.738849","article-title":"Early growth response 1 (Egr-1) is a transcriptional activator of beta-secretase 1 (BACE-1) in the brain","volume":"291","author":"Qin","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2018.03.009_bb0205","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.ajpath.2017.04.018","article-title":"Inhibition of early growth response 1 in the hippocampus alleviates neuropathology and improves cognition in an Alzheimer model with plaques and tangles","volume":"187","author":"Qin","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mcn.2018.03.009_bb0210","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1073\/pnas.092136199","article-title":"Tau is essential to beta-amyloid-induced neurotoxicity","volume":"99","author":"Rapoport","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2018.03.009_bb0215","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model","volume":"316","author":"Roberson","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.mcn.2018.03.009_bb0220","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/WNL.57.2.366-a","article-title":"The cystatin C polymorphism is not associated with early onset Alzheimer's disease","volume":"57","author":"Roks","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2018.03.009_bb0225","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.neurobiolaging.2003.11.006","article-title":"Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation","volume":"25","author":"Sastre","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mcn.2018.03.009_bb0230","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25\u202fyears","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.mcn.2018.03.009_bb0235","doi-asserted-by":"crossref","first-page":"41340","DOI":"10.1074\/jbc.M006219200","article-title":"Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice","volume":"275","author":"Spittaels","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2018.03.009_bb0240","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1159\/000125670","article-title":"Lack of an association between Alzheimer's disease and the cystatin C (CST3) gene G73A polymorphism in Mainland Chinese","volume":"25","author":"Wang","year":"2008","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.mcn.2018.03.009_bb0245","article-title":"Cystatin C shifts APP processing from amyloid-beta production towards non-amyloidgenic pathway in brain endothelial cells","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.mcn.2018.03.009_bb0250","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1073\/pnas.122062299","article-title":"Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damage","volume":"99","author":"Watcharasit","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2018.03.009_bb0255","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s004010050513","article-title":"Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I\/glycogen synthase kinase-3 beta and cyclin-dependent kinase 5, a component of TPK II","volume":"92","author":"Yamaguchi","year":"1996","journal-title":"Acta Neuropathol."}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743117304037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743117304037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T19:37:44Z","timestamp":1660678664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044743117304037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":51,"alternative-id":["S1044743117304037"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2018.03.009","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cystatin C promotes tau protein phosphorylation and causes microtubule instability by inhibiting intracellular turnover of GSK3\u03b2 in neurons","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcn.2018.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}